The New England Journal of Medicine
176 FOLLOWERS
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles and editorial opinions on a wide variety of topics of importance to biomedical science and clinical practice.
The New England Journal of Medicine
1M ago
Blood-Based Test for Colorectal Cancer Screening In a cohort at average risk for colorectal cancer, a cell-free DNA blood-based test had 83% sensitivity for colorectal cancer, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions ..read more
The New England Journal of Medicine
2M ago
In this randomized trial, benralizumab was noninferior to mepolizumab for the induction of remission in patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ..read more
The New England Journal of Medicine
3M ago
meningitis occurred in early 2023 in association with epidural anesthesia in Mexico. Descriptions of 13 cases and associated management are presented ..read more
The New England Journal of Medicine
3M ago
Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years ..read more
The New England Journal of Medicine
4M ago
In this phase 1–2 trial, the TK inhibitor repotrectinib led to an objective response in 79% of patients with fusion–positive NSCLC and no previous ROS1 TK inhibitor use. Median progression-free survival was nearly 3 years ..read more
The New England Journal of Medicine
4M ago
In a trial involving patients with infrapopliteal artery disease, the use of a drug-eluting resorbable scaffold was superior to angioplasty in reducing reintervention and maintaining patency at 1 year ..read more
The New England Journal of Medicine
4M ago
Medial Branch Blocks and Radiofrequency Ablation This video reviews the indications for medial branch blocks and radiofrequency ablation for chronic low back pain from facet joints ..read more
The New England Journal of Medicine
4M ago
Percutaneous Coronary Intervention for Stable Angina In a randomized trial of PCI in patients with stable angina who were receiving little or no antianginal medication and had documented ischemia, PCI resulted in a better health status with respect to angina than placebo at 12 weeks ..read more
The New England Journal of Medicine
5M ago
The addition of subcutaneous daratumumab to bortezomib, lenalidomide, and dexamethasone therapy and to lenalidomide maintenance therapy had a significant benefit on progression-free survival among patients with multiple myeloma ..read more
The New England Journal of Medicine
6M ago
Percutaneous Coronary Intervention for Stable Angina In a randomized trial of PCI in patients with stable angina who were receiving little or no antianginal medication and had documented ischemia, PCI resulted in a better health status with respect to angina than placebo at 12 weeks ..read more